Efficacy of Pegylated Liposomal Doxorubicin in Low-Grade Serous Ovarian Carcinoma

Peter G. Rose; Milena Radeva; Chad M. Michener; Nicholas Link; Fadi Adbul-Karim

doi:10.1097/IGC.0000000000000977

Article info

Ovarian Cancer

Efficacy of Pegylated Liposomal Doxorubicin in Low-Grade Serous Ovarian Carcinoma

Authors

Peter G. Rose Section of Gynecologic Oncology, Women's Health Institute; PubMed articles Google scholar articles
Milena Radeva Quantitative Health Sciences; PubMed articles Google scholar articles
Chad M. Michener Section of Gynecologic Oncology, Women's Health Institute; PubMed articles Google scholar articles
Nicholas Link Department of Pharmacy; and PubMed articles Google scholar articles
Fadi Adbul-Karim Department of Pathology, Cleveland Clinic Healthcare System, Cleveland, OH. PubMed articles Google scholar articles

Address correspondence and reprint requests to Peter G. Rose, MD, A-81, 9500 Euclid Ave, Cleveland, OH 44195. E-mail: rosep@ccf.org.

Citation

Rose PG, Radeva M, Michener CM, et al

Efficacy of Pegylated Liposomal Doxorubicin in Low-Grade Serous Ovarian Carcinoma

International Journal of Gynecologic Cancer 2017;27:907-911.

Publication history

Received November 30, 2016
First published June 1, 2017.

Online issue publication

February 26, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password